AstraZeneca flop a fresh blow to cancer immunotherapy combination – WHTC
WHTC |
AstraZeneca flop a fresh blow to cancer immunotherapy combination
WHTC By Ben Hirschler. LONDON (Reuters) – The concept of combining two immunotherapy drugs to fight lung cancer – not so long ago one of the hottest ideas in cancer research – has suffered a fresh blow from the failure of an AstraZeneca clinical study … UPDATE 1-AstraZeneca flop a fresh blow to cancer immunotherapy combination |
